Skip to content

Novo Real-World Studies Link Wegovy to Lower Liver Enzymes and Weight in MASH, Presented at The Liver Meeting 2026

November 8, 2026 · 9 min

Show notes

Novo Nordisk presented two real-world studies of Wegovy (semaglutide 2.4 mg) in adults with MASH at The Liver Meeting 2026 (AASLD) in Denver on November 6, 2026. In PLATINUM-Truveta, 2,873 adults who started semaglutide were compared with 2,285 who started resmetirom (Rezdiffra). At six months, semaglutide was associated with larger reductions in weight (18.9 lb vs 5.6 lb), AST and HbA1c; the ALT difference was not statistically significant, and LDL fell more with resmetirom. In RHODIUM-2, 2,479 semaglutide starters were compared with 70,702 people with MASH who did not start it, with larger 12-month reductions in ALT, AST and weight. Both studies were retrospective and observational: they show associations, not cause and effect, and they measured blood markers and weight, not liver scarring or clinical outcomes. We put the new data next to what the randomized ESSENCE trial showed and what FDA's August 2025 accelerated approval of Wegovy for MASH requires, with ESSENCE's 240-week outcome results still pending.

Sources

  • Novo Nordisk press release (Nov 6, 2026), PLATINUM-Truveta and RHODIUM-2 results: prnewswire.com
  • Novo Nordisk U.S. press release (Oct 28, 2026), Liver Meeting 2026 abstract slate: novonordisk-us.com
  • U.S. FDA (Aug 15, 2025), FDA Approves Treatment for Serious Liver Disease Known as 'MASH': fda.gov
  • EconoTimes (Nov 7, 2026): econotimes.com
  • Peptide Policy Watch (Nov 5, 2026, updated Nov 7), ESSENCE and the Denver program: peptidepolicywatch.com

Cover: original code-generated illustration (no photo).

This episode is for information only and is not medical advice. Always talk to your doctor before starting, stopping, or changing any medication.

Visit glp1newspaper.com for today's stories and free email alerts.

All episodes of GLP-1 Newspaper: Daily Ozempic, Zepbound & Weight-Loss Drug News

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.